AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
187.27
+1.88 (1.01%)
Jun 26, 2025, 12:52 PM - Market open
AbbVie Revenue
AbbVie had revenue of $13.34B in the quarter ending March 31, 2025, with 8.39% growth. This brings the company's revenue in the last twelve months to $57.37B, up 5.45% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$57.37B
Revenue Growth
+5.45%
P/S Ratio
5.72
Revenue / Employee
$1,043,036
Employees
55,000
Market Cap
330.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
Thermo Fisher Scientific | 42.90B |
ABBV News
- 1 day ago - Elahere Market Opportunities and Strategies to 2034: Abbvie Secures European Approval for Elahere in Platinum-Resistant Ovarian Cancer - GlobeNewsWire
- 1 day ago - My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys - Seeking Alpha
- 2 days ago - 2 Dividend Aristocrats Bargains To Buy And 'Never Let Go' - Seeking Alpha
- 2 days ago - 3 dividend stocks investors can look for stability as Iran attacks US base in Qatar - Invezz
- 6 days ago - I'm Buying Dividend Giants At Huge Discounts - Seeking Alpha
- 6 days ago - AbbVie Declares Quarterly Dividend - PRNewsWire
- 8 days ago - AbbVie's migraine drug meets main goal of late-stage study - Reuters
- 8 days ago - AbbVie Announces New Data Demonstrating Atogepant (QULIPTA® / AQUIPTA®) Achieves Superiority Across All Endpoints in Phase 3 Head-to-Head Study Compared to Topiramate for Migraine Prevention - PRNewsWire